Business Standard

Sunday, December 22, 2024 | 07:28 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Perverse incentives

Genomic surveillance vital for global public health

omicron
Premium

Microscopic view of covid-19 omicron variant or B.1.1.529. 3D rendering

Business Standard Editorial Comment Mumbai
The newly discovered variant of Covid-19, named Omicron by the World Health Organization, has now been identified in multiple countries around the world. There is no clear scientific evidence yet as to whether it exhibits immunity escape, which would put those who are vaccinated or have recovered from a previous case of Covid-19 at risk. Nor is it clear if it is more or less severe in terms of hospitalisation or fatalities than the now dominant Delta variant. Yet stringent travel bans targeting southern African countries have already come into force. South African President Cyril Ramaphosa said in a speech

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in